Literature DB >> 24400341

The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.

Madelijn H Oudegeest-Sander, Marcel G M Olde Rikkert, Paul Smits, Dick H J Thijssen, Arie P J van Dijk, Benjamin D Levine, Maria T E Hopman.   

Abstract

Aging leads to accumulation of irreversible advanced glycation end-products (AGEs), contributing to vascular stiffening and endothelial dysfunction. When combined with the AGE-crosslink breaker Alagebrium, exercise training reverses cardiovascular aging in experimental animals. This study is the first to examine the effect of Alagebrium, with and without exercise training, on endothelial function, arterial stiffness and cardiovascular risk in older individuals. Forty-eight non-exercising individuals (mean age 70 ± 4 years) without manifest diseases or use of medication were allocated into 4 groups for a 1-year intervention: Exercise training &amp; Alagebrium (200 mg/day); exercise training &amp; placebo; no exercise training &amp; Alagebrium (200 mg/day); and no exercise training &amp; placebo. We performed a maximal exercise test (VO2max) and measured endothelial function using venous occlusion plethysmography and intra-arterial infusion of acetylcholine, sodium nitroprusside and NG-monomethyl-l-arginine. Arterial stiffness was measured using pulse wave velocity. Cardiovascular risk was calculated using the Lifetime Risk Score (LRS). In the exercise training groups, LRS and VO2max improved significantly (23.9 ± 4.5 to 27.2 ± 4.6mLO2/min/kg, p < 0.001). Endothelial response to the vasoactive substances did not change, nor did arterial stiffness in any of the four groups. In conclusion, one year of exercise training significantly improved physical fitness and lifetime risk for cardiovascular disease without affecting endothelial function or arterial stiffness. The use of the AGE-crosslink breaker Alagebrium had no independent effect on vascular function, nor did it potentiate the effect of exercise training. Despite the clinical benefits of exercise training for older individuals, neither exercise training nor Alagebrium (alone or in combination) was able to reverse the vascular effects of decades of sedentary aging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24400341      PMCID: PMC3934851          DOI: 10.1016/j.exger.2013.10.009

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  34 in total

1.  Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes.

Authors:  S Taddei; F Galetta; A Virdis; L Ghiadoni; G Salvetti; F Franzoni; C Giusti; A Salvetti
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 2.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

3.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

Review 4.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

5.  Preserved alpha-adrenergic tone in the leg vascular bed of spinal cord-injured individuals.

Authors:  Miriam Kooijman; Gerard A Rongen; Paul Smits; Maria T E Hopman
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

6.  Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men.

Authors:  C A DeSouza; L F Shapiro; C M Clevenger; F A Dinenno; K D Monahan; H Tanaka; D R Seals
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

7.  A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.

Authors:  P V Vaitkevicius; M Lane; H Spurgeon; D K Ingram; G S Roth; J J Egan; S Vasan; D R Wagle; P Ulrich; M Brines; J P Wuerth; A Cerami; E G Lakatta
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

8.  From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs.

Authors:  M J Joyner; N M Dietz; J T Shepherd
Journal:  J Appl Physiol (1985)       Date:  2001-12

Review 9.  Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.

Authors:  Susan J Zieman; David A Kass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness.

Authors:  Jochen Steppan; Huang Tran; Alexandre M Benjo; Laxsmi Pellakuru; Viachaslau Barodka; Sungwoo Ryoo; Sineád M Nyhan; Craig Lussman; Gaurav Gupta; Anthony R White; Joao P Daher; Artin A Shoukas; Benjamin D Levine; Dan E Berkowitz
Journal:  Exp Gerontol       Date:  2012-04-28       Impact factor: 4.032

View more
  27 in total

Review 1.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

Review 2.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

Review 3.  Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli.

Authors:  Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 4.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 5.  Arterial structure and function in vascular ageing: are you as old as your arteries?

Authors:  Dick H J Thijssen; Sophie E Carter; Daniel J Green
Journal:  J Physiol       Date:  2015-07-27       Impact factor: 5.182

Review 6.  Healthy lifestyle-based approaches for successful vascular aging.

Authors:  Matthew J Rossman; Thomas J LaRocca; Christopher R Martens; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2018-09-13

Review 7.  Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

Authors:  Raquel López-Díez; Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochim Biophys Acta       Date:  2016-05-08

Review 8.  Aortic Stiffness in Aging and Hypertension: Prevention and Treatment with Habitual Aerobic Exercise.

Authors:  Gary L Pierce
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

9.  Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population.

Authors:  Otto Mayer; Jitka Seidlerová; Jan Filipovský; Petra Vágovičová; Peter Wohlfahrt; Renata Cífková; Jindra Windrichová; Ondřej Topolčan
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

Review 10.  Therapeutic modification of arterial stiffness: An update and comprehensive review.

Authors:  Ching-Fen Wu; Pang-Yen Liu; Tsung-Jui Wu; Yuan Hung; Shih-Ping Yang; Gen-Min Lin
Journal:  World J Cardiol       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.